Examining the Role of Female Endogenous Sex Hormones in Eccentric Exercise
1 other identifier
interventional
30
1 country
1
Brief Summary
The fluctuating concentrations of female sex hormones, namely estrogen and progesterone may have an effect on the ability of the tissue to withstand challenging exercise conditions, such as eccentric exercise. These sex hormones have also been purported to influence the perceived difficulty of exercise. This study aims to uncover how the different estrogen and progesterone concentrations present throughout the menstrual cycle effect perceived readiness to perform, perceptions of difficulty, and different recovery metrics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2023
CompletedFirst Posted
Study publicly available on registry
July 7, 2023
CompletedStudy Start
First participant enrolled
March 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
March 25, 2026
March 1, 2026
1.2 years
June 20, 2023
March 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Preparedness to perform
Perceived readiness will be measured on an 11 point numeric rating scale (NRS) with 0 being not ready at all, and 10 being most prepared
Pre exercise
Rating of difficulty
Perceived difficulty will be measured on a 11 point numeric rating scale called the OMNI res throughout the duration of exercise.
30 minutes
Inflammatory markers
Inflammatory markers (IL-6, IL-8, TNF-alpha, and IL-10) will be measured in blood serum to understand how the concentration of estrogen changes the inflammatory response to damaging exercise.
Change over time (pre/post, 24 hour, 48 hour)
Counter movement jump height
A countermovement jump (CMJ) will be performed on VALD ForceDecks to determine muscle function overtime.
Change over time (pre/post, 24 hour, 48 hour)
Passive Delayed Onset Muscle Soreness (DOMS)
DOMS will be assessed as participants are stationary to assess their perception of muscle damage over time.
Change over time (pre/post, 24 hour, 48 hour)
Active Delayed Onset Muscle Soreness (DOMS)
DOMS will be assessed as participants complete a wall sit to assess their perception of muscle soreness over time.
Change over time (pre/post, 24 hour, 48 hour)
Study Arms (3)
Low estrogen; low progesterone
EXPERIMENTALParticipants will come in while on their period. During this time estrogen and progesterone concentrations are low.
High estrogen; low progesterone
EXPERIMENTALParticipants will come in just before ovulation, when estrogen concentrations are high and progesterone concentrations remain low.
Medium estrogen; high progesterone
EXPERIMENTALParticipants will come in just after ovulation when estrogen concentrations are at a medium level, and progesterone concentrations are high.
Interventions
Participants will complete a 10 x 10 eccentric leg extension on a Cybex Norm dynamometer. Upon arrival, participants will be asked their perceived readiness to perform on a 11 point numeric rating scale. Before the running protocol a baseline blood sample will be collected, as well as passive and active delayed onset muscle soreness (DOMS), a countermovement jump. Half way through each set (i.e., after the 5th repetition) participants will be asked to rank their level of difficulty on a 11 point OMNI Res scale. This will occur during each set. Participants will have follow up blood draws, measures of muscle function (i.e, jump height) and soreness measured immediately after and 24 and 48 hours post-exercise.
Eligibility Criteria
You may qualify if:
- years of age
- BMI of 18.5-29.9 as a BMI below or above these cut points results in highly varied menstrual cycle lengths \[15\]
- Not taking contraception or other types of medication that could influence reproductive status
- Regular menstruation
- Non-pregnant
- Medically free from chronic diseases
- Novel to downhill running
- Weight greater than or equal to 110 lbs
- Not taking exogenous hormones
- Not suffering from known gynecological disease (i.e., PCOS, endometriosis, etc.) that may influence menstrual cycle regularity
You may not qualify if:
- Amenorrhea or oligomenorrhea
- Perimenopausal or menopausal
- Recreational or professional trail or downhill runner
- On a form of contraception
- Cardiac disability
- Pacemaker
- Arterial disease
- Uncontrolled hemorrhage
- Blood clots
- Pregnant or trying to become pregnant
- Cancerous lesions
- Sensory or mental impairment
- Unstable fractures
- Weight less than 110 lbs
- Suffering from gynecological disease (i.e., PCOS, endometriosis, etc.) that may influence menstrual cycle regularity
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Exercise Research Center
Los Angeles, California, 90033, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 20, 2023
First Posted
July 7, 2023
Study Start
March 7, 2025
Primary Completion (Estimated)
May 30, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
March 25, 2026
Record last verified: 2026-03